Skip to main content
Erschienen in: Infection 3/2014

01.06.2014 | Brief Report

IGRA-positive patients and interferon-gamma/interleukin-2 signatures: Can the Fluorospot assay provide further information?

verfasst von: P. Bittel, D. Mayor, P. Iseli, T. Bodmer, F. Suter-Riniker

Erschienen in: Infection | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

A goal of testing for latent tuberculosis (TB) infection is to identify individuals who are at increased risk for the development of active TB. No laboratory tool is currently available to distinguish between individuals in the process of progressing from latent TB infection towards active disease and those who are not. Determination of the interferon-gamma and interleukin-2 T cell signature might provide an additional and rapid tool to evaluate treatment necessity and clinical management of a patient. Here, we present three cases of interferon-gamma release assay-positive patients with differing interferon-gamma and interleukin-2 signatures when analyzed by the Fluorospot assay.
Literatur
3.
Zurück zum Zitat Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008;149:177–84.PubMedCentralPubMedCrossRef Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008;149:177–84.PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Diel R, Loddenkemper R, Nienhaus A. Predictive value of interferon-gamma release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis. Chest. 2012;142:63–75. doi:10.1378/chest.11-3157.PubMedCrossRef Diel R, Loddenkemper R, Nienhaus A. Predictive value of interferon-gamma release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis. Chest. 2012;142:63–75. doi:10.​1378/​chest.​11-3157.PubMedCrossRef
8.
Zurück zum Zitat Millington KA, Innes JA, Hackforth S, Hinks TS, Deeks JJ, Dosanjh DP, et al. Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J Immunol. 2007;178:5217–26.PubMedCentralPubMedCrossRef Millington KA, Innes JA, Hackforth S, Hinks TS, Deeks JJ, Dosanjh DP, et al. Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J Immunol. 2007;178:5217–26.PubMedCentralPubMedCrossRef
10.
12.
Zurück zum Zitat Ringshausen FC, Nienhaus A, Torres Costa J, Knoop H, Schlosser S, Schultze-Werninghaus G, et al. Within-subject variability of Mycobacterium tuberculosis-specific gamma interferon responses in German health care workers. Clin Vaccine Immunol. 2011;18:1176–82. doi:10.1128/CVI.05058-11.PubMedCentralPubMedCrossRef Ringshausen FC, Nienhaus A, Torres Costa J, Knoop H, Schlosser S, Schultze-Werninghaus G, et al. Within-subject variability of Mycobacterium tuberculosis-specific gamma interferon responses in German health care workers. Clin Vaccine Immunol. 2011;18:1176–82. doi:10.​1128/​CVI.​05058-11.PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Kim SY, Park MS, Kim YS, Kim SK, Chang J, Kang YA. Conversion rates of an interferon-gamma release assay and the tuberculin skin test in the serial monitoring of healthcare workers. Infection. 2013;41:511–6. doi:10.1007/s15010-012-0356-0.PubMedCrossRef Kim SY, Park MS, Kim YS, Kim SK, Chang J, Kang YA. Conversion rates of an interferon-gamma release assay and the tuberculin skin test in the serial monitoring of healthcare workers. Infection. 2013;41:511–6. doi:10.​1007/​s15010-012-0356-0.PubMedCrossRef
Metadaten
Titel
IGRA-positive patients and interferon-gamma/interleukin-2 signatures: Can the Fluorospot assay provide further information?
verfasst von
P. Bittel
D. Mayor
P. Iseli
T. Bodmer
F. Suter-Riniker
Publikationsdatum
01.06.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 3/2014
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-014-0588-2

Weitere Artikel der Ausgabe 3/2014

Infection 3/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.